These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32363793)

  • 21. Temperature elevation, bacterial growth and antibiotic activity.
    Manzella JP; Roberts NJ; Robertson RG; Hoder GB
    J Antimicrob Chemother; 1980 Nov; 6(6):795-8. PubMed ID: 7440470
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents.
    Brown MR; Williams P
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():7-14. PubMed ID: 3980338
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of the postantibiotic effect.
    Ebert SC
    Clin Pharm; 1992 Oct; 11(10):876-7. PubMed ID: 1341994
    [No Abstract]   [Full Text] [Related]  

  • 24. General Mechanisms Leading to Persister Formation and Awakening.
    Wilmaerts D; Windels EM; Verstraeten N; Michiels J
    Trends Genet; 2019 Jun; 35(6):401-411. PubMed ID: 31036343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of biofilms to antimicrobial agents.
    Brown MR; Gilbert P
    J Appl Bacteriol; 1993; 74 Suppl():87S-97S. PubMed ID: 8349537
    [No Abstract]   [Full Text] [Related]  

  • 26. Postantibiotic effect in vitro.
    Fuursted K
    APMIS Suppl; 1999; 90():1-23. PubMed ID: 10189835
    [No Abstract]   [Full Text] [Related]  

  • 27. Combatting bacterial persister cells.
    Wood TK
    Biotechnol Bioeng; 2016 Mar; 113(3):476-83. PubMed ID: 26264116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Method of polymerase chain reaction in laboratory practice].
    Dubinina IG; Shcherbo SN; Makarov VB
    Klin Lab Diagn; 1997 Jul; (7):4-6. PubMed ID: 9340093
    [No Abstract]   [Full Text] [Related]  

  • 29. Protocols for Studying Inhibition and Eradication of Bacterial Biofilms by Antimicrobial Peptides.
    Sarojini V
    Methods Mol Biol; 2017; 1548():323-330. PubMed ID: 28013515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic basis of erythromycin resistance in oral bacteria.
    Villedieu A; Diaz-Torres ML; Roberts AP; Hunt N; McNab R; Spratt DA; Wilson M; Mullany P
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2298-301. PubMed ID: 15155239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of antibiotic resistance in bacteria.
    Satta G; Fontana R
    Chemioterapia; 1987 Jun; 6(2 Suppl):190-2. PubMed ID: 3509388
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies for combating persister cell and biofilm infections.
    Wood TK
    Microb Biotechnol; 2017 Sep; 10(5):1054-1056. PubMed ID: 28696066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of factors affecting the 'critical population' density of inocula on the determination of bacterial susceptibility to antibiotics by disc diffusion methods.
    Hedges AJ
    J Antimicrob Chemother; 1999 Feb; 43(2):313. PubMed ID: 11252343
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic tolerance among clinical isolates of bacteria.
    Handwerger S; Tomasz A
    Rev Infect Dis; 1985; 7(3):368-86. PubMed ID: 3895353
    [No Abstract]   [Full Text] [Related]  

  • 35. What do we mean by antibiotic resistance?
    Bush K
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):165-7. PubMed ID: 15482181
    [No Abstract]   [Full Text] [Related]  

  • 36. Persister cells and the riddle of biofilm survival.
    Lewis K
    Biochemistry (Mosc); 2005 Feb; 70(2):267-74. PubMed ID: 15807669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatiotemporal microbial evolution on antibiotic landscapes.
    Baym M; Lieberman TD; Kelsic ED; Chait R; Gross R; Yelin I; Kishony R
    Science; 2016 Sep; 353(6304):1147-51. PubMed ID: 27609891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms and clinical implications of bacterial persistence.
    Michiels JE; Van den Bergh B; Verstraeten N; Michiels J
    Drug Resist Updat; 2016 Nov; 29():76-89. PubMed ID: 27912845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of ciprofloxacin.
    Ferrara A; Donnetta A; Grassi FA; Gialdroni Grassi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):130-1. PubMed ID: 3151333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.